Our top pick for
Informatica Inc is a software-infrastructure business based in the US. Informatica shares (INFA) are listed on the NYSE and all prices are listed in US Dollars. Informatica employs 5,500 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$21.37|
|52-week range||$16.20 - $40.13|
|50-day moving average||$19.68|
|200-day moving average||$25.11|
|Wall St. target price||$29.10|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-0.39|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2022-06-30)||2.89%|
|1 month (2022-06-07)||5.32%|
|3 months (2022-04-07)||12.06%|
|6 months (2022-01-07)||-29.05%|
|1 year (2021-07-03)||N/A|
|2 years (2020-07-03)||N/A|
|3 years (2019-07-03)||N/A|
|5 years (2017-07-03)||N/A|
Valuing Informatica stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Informatica's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Informatica's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $240.1 million.
The EBITDA is a measure of a Informatica's overall financial performance and is widely used to measure a its profitability.
To put Informatica's EBITDA into context you can compare it against that of similar companies.
|Revenue TTM||$1.5 billion|
|Operating margin TTM||3.26%|
|Gross profit TTM||$1.2 billion|
|Return on assets TTM||0.62%|
|Return on equity TTM||-6.36%|
|Market capitalisation||$6 billion|
TTM: trailing 12 months
We're not expecting Informatica to pay a dividend over the next 12 months.
You may also wish to consider:
Informatica Inc. develops an artificial intelligence-powered platform that connects, manages, and unifies data across multi-cloud, hybrid systems at enterprise scale in the United States. The company's platform includes a suite of interoperable data management products, including data integration products to ingest, transform, and integrate data; API and application integration products that enable users to create and manage APIs and integration processes for app-to-app synchronization, business process orchestration, B2B partner management, application development, and API management; data quality products to profile, cleanse, standardize, and enrich data to deliver accurate, complete, and consistent data sets for analytics, data science, governance, and other initiatives; and master data management products to create an authoritative single source of truth of business-critical data to reduce data related errors and remove redundancies. Its platform also includes customer and business 360 products to create, visualize, and browse comprehensive 360-degree views of business-critical data; data catalog products that enables customers to quickly find, access, and understand enterprise data using a simple Google-like search experience; and governance and privacy products that help users govern data, enable compliance with regulatory and corporate policies, and drive broader data consumption. The company also offers maintenance and professional services. Informatica Inc. was founded in 1993 and is headquartered in Redwood City, California.
Everything we know about the Citrine Global IPO, plus information on how to buy in.
Everything we know about the Genelux Corporation IPO, plus information on how to buy in.
Everything we know about the Magic Empire Global IPO, plus information on how to buy in.
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.